Neuroleptic malignant syndrome: an easily overlooked neurologic emergency
Ramadhan Oruch,1 Ian F Pryme,2 Bernt A Engelsen,3 Anders Lund4 1Department of Pharmacology and Toxicology, School of Pharmacy, Benghazi University, Benghazi, Libya; 2Department of Biomedicine, 3Department of Clinical Medicine, Section of Neurology, 4Department of Clinical Medicine, Section of Psych...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c431170cea9b4762b3ce7699f12cc8d5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c431170cea9b4762b3ce7699f12cc8d5 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c431170cea9b4762b3ce7699f12cc8d52021-12-02T00:23:57ZNeuroleptic malignant syndrome: an easily overlooked neurologic emergency1178-2021https://doaj.org/article/c431170cea9b4762b3ce7699f12cc8d52017-01-01T00:00:00Zhttps://www.dovepress.com/neuroleptic-malignant-syndrome-an-easily-overlooked-neurologic-emergen-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Ramadhan Oruch,1 Ian F Pryme,2 Bernt A Engelsen,3 Anders Lund4 1Department of Pharmacology and Toxicology, School of Pharmacy, Benghazi University, Benghazi, Libya; 2Department of Biomedicine, 3Department of Clinical Medicine, Section of Neurology, 4Department of Clinical Medicine, Section of Psychiatry, University of Bergen, Bergen, Norway Abstract: Neuroleptic malignant syndrome is an unpredictable iatrogenic neurologic emergency condition, mainly arising as an idiosyncratic reaction to antipsychotic agent use. It is characterized by distinctive clinical features including a change in mental status, generalized rigidity, hyperpyrexia, and dysautonomia. It can be lethal if not diagnosed and treated properly. Mortality and morbidity attributed to this syndrome have recently declined markedly due to greater awareness, earlier diagnosis, and intensive care intervention. In most cases, the syndrome occurs as a result of a rapid increase in a dose of neuroleptic, especially one of the long-acting ones. Pathophysiology behind this syndrome is attributed to a dopamine receptor blockade inside the neurons rendered by the offending drug and excessive calcium release from the sarcoplasmic reticulum of skeletal myocytes. Laboratory tests, although not diagnostic, may assist in assessing the severity of the syndrome and also the consequent complications. The syndrome has been described in all age groups and occurs more in males than in females. Genetics appears to be central regarding the etiology of the syndrome. Stopping the use of the offending agent, cold intravenous fluids, and removal of the causative agent and its possible active metabolites is the cornerstone of treatment. Periodic observation of psychotic patients recently started on antipsychotic medications, especially those being treated with depot preparations, may aid to an early diagnosis of the syndrome and lead to early treatment. Keywords: neuroleptic malignant syndrome, dopamine receptors, rhabdomyolysis, renal shutdown, hyperpyrexia, sarcoplasmic reticulumOruch RPryme IFEngelsen BALund ADove Medical PressarticleNeuroleptic malignant syndromedopamine receptorsrhabdomyolysisrenal shutdownhyperpyrexiasarcoplasmic reticulum.Neurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 13, Pp 161-175 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Neuroleptic malignant syndrome dopamine receptors rhabdomyolysis renal shutdown hyperpyrexia sarcoplasmic reticulum. Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
Neuroleptic malignant syndrome dopamine receptors rhabdomyolysis renal shutdown hyperpyrexia sarcoplasmic reticulum. Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Oruch R Pryme IF Engelsen BA Lund A Neuroleptic malignant syndrome: an easily overlooked neurologic emergency |
description |
Ramadhan Oruch,1 Ian F Pryme,2 Bernt A Engelsen,3 Anders Lund4 1Department of Pharmacology and Toxicology, School of Pharmacy, Benghazi University, Benghazi, Libya; 2Department of Biomedicine, 3Department of Clinical Medicine, Section of Neurology, 4Department of Clinical Medicine, Section of Psychiatry, University of Bergen, Bergen, Norway Abstract: Neuroleptic malignant syndrome is an unpredictable iatrogenic neurologic emergency condition, mainly arising as an idiosyncratic reaction to antipsychotic agent use. It is characterized by distinctive clinical features including a change in mental status, generalized rigidity, hyperpyrexia, and dysautonomia. It can be lethal if not diagnosed and treated properly. Mortality and morbidity attributed to this syndrome have recently declined markedly due to greater awareness, earlier diagnosis, and intensive care intervention. In most cases, the syndrome occurs as a result of a rapid increase in a dose of neuroleptic, especially one of the long-acting ones. Pathophysiology behind this syndrome is attributed to a dopamine receptor blockade inside the neurons rendered by the offending drug and excessive calcium release from the sarcoplasmic reticulum of skeletal myocytes. Laboratory tests, although not diagnostic, may assist in assessing the severity of the syndrome and also the consequent complications. The syndrome has been described in all age groups and occurs more in males than in females. Genetics appears to be central regarding the etiology of the syndrome. Stopping the use of the offending agent, cold intravenous fluids, and removal of the causative agent and its possible active metabolites is the cornerstone of treatment. Periodic observation of psychotic patients recently started on antipsychotic medications, especially those being treated with depot preparations, may aid to an early diagnosis of the syndrome and lead to early treatment. Keywords: neuroleptic malignant syndrome, dopamine receptors, rhabdomyolysis, renal shutdown, hyperpyrexia, sarcoplasmic reticulum |
format |
article |
author |
Oruch R Pryme IF Engelsen BA Lund A |
author_facet |
Oruch R Pryme IF Engelsen BA Lund A |
author_sort |
Oruch R |
title |
Neuroleptic malignant syndrome: an easily overlooked neurologic emergency |
title_short |
Neuroleptic malignant syndrome: an easily overlooked neurologic emergency |
title_full |
Neuroleptic malignant syndrome: an easily overlooked neurologic emergency |
title_fullStr |
Neuroleptic malignant syndrome: an easily overlooked neurologic emergency |
title_full_unstemmed |
Neuroleptic malignant syndrome: an easily overlooked neurologic emergency |
title_sort |
neuroleptic malignant syndrome: an easily overlooked neurologic emergency |
publisher |
Dove Medical Press |
publishDate |
2017 |
url |
https://doaj.org/article/c431170cea9b4762b3ce7699f12cc8d5 |
work_keys_str_mv |
AT oruchr neurolepticmalignantsyndromeaneasilyoverlookedneurologicemergency AT prymeif neurolepticmalignantsyndromeaneasilyoverlookedneurologicemergency AT engelsenba neurolepticmalignantsyndromeaneasilyoverlookedneurologicemergency AT lunda neurolepticmalignantsyndromeaneasilyoverlookedneurologicemergency |
_version_ |
1718403765194719232 |